A Drug Utilization Study of Xofigo Use in Sweden

Study identification

• EU PAS number:
  EUPAS8494
• Study ID:
  29028
• Official title and acronym:
  A Drug Utilization Study of Xofigo Use in Sweden
• DARWIN EU® study:
  No
• Study countries:
  Sweden
• Study status:
  Finalised

Research institutions and networks

Institutions

NA

Study timelines

Date when funding contract was signed

Planned:10/10/2014

Actual:10/10/2014

Study start date

Planned:01/05/2015

Actual:15/04/2015

Date of final study report

Planned:15/12/2017

Actual:19/12/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Bayer AG

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)